181 related articles for article (PubMed ID: 17970059)
1. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
[TBL] [Abstract][Full Text] [Related]
2. Crucial role of group IIA phospholipase A2 in pancreatitis-associated adrenal injury in acute necrotizing pancreatitis.
Xu S; Chen C; Wang WX; Huang SR; Yu J; Chen XY
Pathol Res Pract; 2010 Feb; 206(2):73-82. PubMed ID: 19362431
[TBL] [Abstract][Full Text] [Related]
3. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2.
Mannello F; Qin W; Zhu W; Fabbri L; Tonti GA; Sauter ER
Breast Cancer Res Treat; 2008 Sep; 111(2):209-18. PubMed ID: 17932742
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium.
Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L
Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014
[TBL] [Abstract][Full Text] [Related]
5. Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth.
Belinsky GS; Rajan TV; Saria EA; Giardina C; Rosenberg DW
Mol Carcinog; 2007 Feb; 46(2):106-16. PubMed ID: 17091473
[TBL] [Abstract][Full Text] [Related]
6. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
8. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
[TBL] [Abstract][Full Text] [Related]
9. Halogenated phospholipids regulate secretory phospholipase A2 group IIA activity.
Korotaeva A; Samoilova E; Pavlunina T; Panasenko OM
Chem Phys Lipids; 2013; 167-168():51-6. PubMed ID: 23438648
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A
Kuksis A; Pruzanski W
Lipids; 2017 Jun; 52(6):477-488. PubMed ID: 28528433
[TBL] [Abstract][Full Text] [Related]
11. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
[TBL] [Abstract][Full Text] [Related]
12. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
Masuda S; Murakami M; Ishikawa Y; Ishii T; Kudo I
Biochim Biophys Acta; 2005 Oct; 1736(3):200-10. PubMed ID: 16188494
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
[TBL] [Abstract][Full Text] [Related]
14. [Phospholipase A2, group IIa, as an earlier unknown immunohistological marker of cardiac myxoma].
Khaspekov GL; Sheremet'eva GF; Skamrov AV; Nechaenko MA; Vinnitskiĭ LI; Vlasik TN; Goriunova LE; Rutkevich NM; Peklo MM; Bibilashvili RSh
Arkh Patol; 2008; 70(2):31-6. PubMed ID: 18540439
[TBL] [Abstract][Full Text] [Related]
15. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
[TBL] [Abstract][Full Text] [Related]
16. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
[TBL] [Abstract][Full Text] [Related]
17. Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence.
Movert E; Wu Y; Lambeau G; Kahn F; Touqui L; Areschoug T
J Infect Dis; 2013 Dec; 208(12):2025-35. PubMed ID: 23901095
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic properties of stingray Dasyatis pastinaca group V, IIA and IB phospholipases A(2): a comparative study.
Ben Bacha A; Abid I; Horchani H; Mejdoub H
Int J Biol Macromol; 2013 Nov; 62():537-42. PubMed ID: 24120965
[TBL] [Abstract][Full Text] [Related]
19. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
[TBL] [Abstract][Full Text] [Related]
20. A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer.
Chen J; Ye L; Sun Y; Takada Y
Med Chem; 2017; 13(7):606-615. PubMed ID: 28185537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
